Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.44 USD | +0.31% | +1.74% | +4.04% |
Apr. 19 | Lifecore Biomedical Gets Nasdaq Warning Over Delayed Quarterly Report | MT |
Apr. 01 | Lifecore Biomedical, Inc. Provides Revenue Guidance for Full Year Fiscal 2024 | CI |
Financials (USD)
Sales 2024 * | 126M | Sales 2025 * | 145M | Capitalization | 197M |
---|---|---|---|---|---|
Net income 2024 * | 6M | Net income 2025 * | 18M | EV / Sales 2024 * | 1.56 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 1.35 x |
P/E ratio 2024 * |
29.3
x | P/E ratio 2025 * |
11.1
x | Employees | 459 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 95.35% |
Latest transcript on Lifecore Biomedical, Inc.
1 day | +0.31% | ||
1 week | +1.74% | ||
Current month | +0.31% | ||
1 month | +11.23% | ||
3 months | -0.62% | ||
6 months | -8.39% | ||
Current year | +4.04% |
Managers | Title | Age | Since |
---|---|---|---|
James Hall
CEO | Chief Executive Officer | 61 | 17-05-31 |
John Morberg
DFI | Director of Finance/CFO | 60 | 21-01-17 |
Steve Laninga
COO | Chief Operating Officer | - | 19-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Nelson Obus
BRD | Director/Board Member | 77 | 18-10-11 |
Jeffrey Edwards
BRD | Director/Board Member | 64 | 20-10-13 |
Katrina Houde
BRD | Director/Board Member | 66 | 19-08-04 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 9 M€ | +5.00% | - | |
0.00% | 147 M€ | +4.74% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-01 | 6.44 | +0.31% | 109,872 |
24-04-30 | 6.42 | -0.62% | 122,165 |
24-04-29 | 6.46 | -2.05% | 74,201 |
24-04-26 | 6.595 | -0.68% | 110,906 |
24-04-25 | 6.64 | +4.90% | 256,407 |
Delayed Quote Nasdaq, May 01, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+4.04% | 196M | |
+33.25% | 704B | |
+28.59% | 577B | |
-3.55% | 348B | |
+18.16% | 327B | |
+4.36% | 288B | |
+14.81% | 234B | |
+4.93% | 198B | |
-9.78% | 194B | |
-3.69% | 147B |
- Stock Market
- Equities
- LFCR Stock